Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

GCPII Imaging and Cancer

Author(s): C. A. Foss, R. C. Mease, S. Y. Cho, H. J. Kim and M. G. Pomper

Volume 19 , Issue 9 , 2012

Page: [1346 - 1359] Pages: 14

DOI: 10.2174/092986712799462612

Price: $65

Abstract

Glutamate carboxypeptidase II (GCPII) in the central nervous system is referred to as the prostate-specific membrane antigen (PSMA) in the periphery. PSMA serves as a target for imaging and treatment of prostate cancer and because of its expression in solid tumor neovasculature has the potential to be used in this regard for other malignancies as well. An overview of GCPII/PSMA in cancer, as well as a discussion of imaging and therapy of prostate cancer using a wide variety of PSMA-targeting agents is provided.

Keywords: Prostate-specific membrane antigen, PSMA, prostate cancer, molecular imaging, PET, SPECT, Glutamate carboxypeptidase II, malignancies, enzymatic activity, heterogeneous expression


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy